INIS
brucella
100%
mice
81%
genes
44%
control
33%
spleen
32%
host
31%
lungs
29%
growth
28%
vaccines
24%
pathogens
22%
trypanosoma
20%
strains
13%
organs
11%
repair pathways
10%
excision repair
10%
virulence
9%
comparative evaluations
9%
humans
8%
mutants
8%
macrophages
8%
skin
8%
tissues
6%
synthesis
6%
liver
5%
Immunology and Microbiology
Brucella
50%
Mouse
50%
Infectious Agent
30%
Brucella Melitensis
28%
Macrophage
25%
Brucella Abortus
24%
Host-Pathogen Interaction
20%
Trypanosoma
20%
T-Helper Cell
13%
MHC Class II
12%
Excision Repair
10%
DNA Repair
10%
Face
10%
Host Cell
10%
Cell Cycle
10%
Transcription Factors
10%
Type IV Secretion System
10%
T Cell
10%
Escherichia coli
10%
Immunosuppressive Drug
8%
Wild Type
8%
Bacterial Virulence
6%
B Cell
5%
Phagocyte
5%
Neutrophil Granulocyte
5%
Attenuated Vaccine
5%
Live Vaccine
5%
Zoonosis
5%
Transposon
5%
Interleukin
5%
Fatty Acid Metabolism
5%
Purine Synthesis
5%
Mucosal Immune System
5%
Operon
5%
Alveolar Macrophage
5%
Fibroblast
5%
Cell Level
5%
Myeloid
5%
C57BL 6 Mouse
5%
Cytokine
5%
Carbohydrate Metabolism
5%
Keyphrases
T. Brucei
20%
Intranasal Infection
20%
Rational Selection
20%
Next-generation Vaccines
20%
IL-17RA
15%
Intranasal
10%
Intradermal Infection
10%
Interleukin-17 (IL-17)
10%
Methionine Transport
6%
Tryptophan Metabolism
6%
Pulmonary Infection
6%
Optimal Growth
6%
Tn-seq
6%
Lung Condition
6%
Asthmatic Mice
6%
Direct Repair
6%
Direct Basis
6%
Base Excision Repair Pathway
6%
Skin Tissue
5%
CD140a
5%
Intranasal Route
5%
Infectious Reservoir
5%
Intraperitoneal Infection
5%
Ly6G
5%
Intradermal Route
5%
Live Attenuated Vaccine
5%
Intraperitoneal Route
5%
Pathogen Persistence
5%
Rational Development
5%
Vacuolar Trafficking
5%
Mucosal Infection
5%
Early Control
5%
CD4 T Cells
5%
Response Control
5%
Mucosal Immune Response
5%
